Table of Content

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Dementia Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Dementia Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Dementia Drugs Market by Drug Class
5.1. Introduction
5.2. Cholinesterase Inhibitors
5.3. NMDA Antagonists and its Combination Drugs
6. Global Dementia Drugs Market by Indication
6.1. Introduction
6.2. Lewy Body Dementia
6.3. Parkinsons Disease Dementia
6.4. Alzheimers Disease
6.5. Vascular Dementia
6.6. Others
7. Global Dementia Drugs Market by Distribution Channel
7.1. Introduction
7.2. Retail Pharmacies
7.3. Hospital Pharmacies
7.4. Online Pharmacies
8. Global Dementia Drugs Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Annovis Bio
12.2.2. AstraZeneca
12.2.3. Athira Pharma
12.2.4. Aurobindo Pharma
12.2.5. Biogen
12.2.6. Eisai Co. Ltd
12.2.7. Eli Lilly and Company
12.2.8. GlaxoSmithKline PLC
12.2.9. Johnson and Johnson
12.2.10. Merck & Co. Inc.
12.2.11. Pfizer Inc.
12.2.12. SK Capital (Apotex Pharmaceutical Holdings Inc.)
12.2.13. Teva Pharmaceuticals
12.2.14. Zydus Cadila
?

List of Figures

Figure 1: Global Dementia Drugs Market (in US$ Million), 2019-2023
Figure 2: Global Dementia Drugs Market by Drug Class, 2023
Figure 3: Global Dementia Drugs Market by Indication, 2023
Figure 4: Global Dementia Drugs Market by Distribution Channel, 2023
Figure 5: Global Dementia Drugs Market by Region, 2023
Figure 6: Global Dementia Drugs Market (in US$ Million), 2024-2033
Figure 7: Global Dementia Drugs Market by Drug Class (in %), 2023 & 2033
Figure 8: Global Cholinesterase Inhibitors Dementia Drugs Market (in US$ Million), 2019-2023
Figure 9: Global Cholinesterase Inhibitors Dementia Drugs Market (in US$ Million), 2024-2033
Figure 10: Global NMDA Antagonists and its Combination Drugs Dementia Drugs Market (in US$ Million), 2019-2023
Figure 11: Global NMDA Antagonists and its Combination Drugs Dementia Drugs Market (in US$ Million), 2024-2033
Figure 12: Global Dementia Drugs Market by Indication (in %), 2023 & 2033
Figure 13: Global Lewy Body Dementia Drugs Market (in US$ Million), 2019-2023
Figure 14: Global Lewy Body Dementia Drugs Market (in US$ Million), 2024-2033
Figure 15: Global Parkinsons Disease Dementia Drugs Market (in US$ Million), 2019-2023
Figure 16: Global Parkinsons Disease Dementia Drugs Market (in US$ Million), 2024-2033
Figure 17: Global Alzheimers Disease Dementia Drugs Market (in US$ Million), 2019-2023
Figure 18: Global Alzheimers Disease Dementia Drugs Market (in US$ Million), 2024-2033
Figure 19: Global Vascular Dementia Drugs Market (in US$ Million), 2019-2023
Figure 20: Global Vascular Dementia Drugs Market (in US$ Million), 2024-2033
Figure 21: Global Other Indications Dementia Drugs Market (in US$ Million), 2019-2023
Figure 22: Global Other Indications Dementia Drugs Market (in US$ Million), 2024-2033
Figure 23: Global Dementia Drugs Market by Distribution Channel (in %), 2023 & 2033
Figure 24: Global Retail Pharmacies Dementia Drugs Market (in US$ Million), 2019-2023
Figure 25: Global Retail Pharmacies Dementia Drugs Market (in US$ Million), 2024-2033
Figure 26: Global Hospital Pharmacies Dementia Drugs Market (in US$ Million), 2019-2023
Figure 27: Global Hospital Pharmacies Dementia Drugs Market (in US$ Million), 2024-2033
Figure 28: Global Online Pharmacies Dementia Drugs Market (in US$ Million), 2019-2023
Figure 29: Global Online Pharmacies Dementia Drugs Market (in US$ Million), 2024-2033
Figure 30: Global Dementia Drugs Market by Region (in %), 2023 & 2033
Figure 31: Europe Dementia Drugs Market (in US$ Million), 2019-2023
Figure 32: Europe Dementia Drugs Market (in US$ Million), 2024-2033
Figure 33: Europe Dementia Drugs Market by Country (in %), 2023 & 2033
Figure 34: Germany Dementia Drugs Market (in US$ Million), 2019-2033
Figure 35: United Kingdom Dementia Drugs Market (in US$ Million), 2019-2033
Figure 36: France Dementia Drugs Market (in US$ Million), 2019-2033
Figure 37: Italy Dementia Drugs Market (in US$ Million), 2019-2033
Figure 38: Spain Dementia Drugs Market (in US$ Million), 2019-2033
Figure 39: Russia Dementia Drugs Market (in US$ Million), 2019-2033
Figure 40: Netherlands Dementia Drugs Market (in US$ Million), 2019-2033
Figure 41: North America Dementia Drugs Market (in US$ Million), 2019-2023
Figure 42: North America Dementia Drugs Market (in US$ Million), 2024-2033
Figure 43: North America Dementia Drugs Market by Country (in %), 2023 & 2033
Figure 44: United States Dementia Drugs Market (in US$ Million), 2019-2033
Figure 45: Canada Dementia Drugs Market (in US$ Million), 2019-2033
Figure 46: Asia Pacific Dementia Drugs Market (in US$ Million), 2019-2023
Figure 47: Asia Pacific Dementia Drugs Market (in US$ Million), 2024-2033
Figure 48: Asia Pacific Dementia Drugs Market by Country (in %), 2023 & 2033
Figure 49: China Dementia Drugs Market (in US$ Million), 2019-2033
Figure 50: Japan Dementia Drugs Market (in US$ Million), 2019-2033
Figure 51: India Dementia Drugs Market (in US$ Million), 2019-2033
Figure 52: South Korea Dementia Drugs Market (in US$ Million), 2019-2033
Figure 53: Australia Dementia Drugs Market (in US$ Million), 2019-2033
Figure 54: Indonesia Dementia Drugs Market (in US$ Million), 2019-2033
Figure 55: Latin America Dementia Drugs Market (in US$ Million), 2019-2023
Figure 56: Latin America Dementia Drugs Market (in US$ Million), 2024-2033
Figure 57: Latin America Dementia Drugs Market by Country (in %), 2023 & 2033
Figure 58: Mexico Dementia Drugs Market (in US$ Million), 2019-2033
Figure 59: Brazil Dementia Drugs Market (in US$ Million), 2019-2033
Figure 60: Argentina Dementia Drugs Market (in US$ Million), 2019-2033
Figure 61: Middle East & Africa Dementia Drugs Market (in US$ Million), 2019-2023
Figure 62: Middle East & Africa Dementia Drugs Market (in US$ Million), 2024-2033
Figure 63: Middle East & Africa Dementia Drugs Market by Country (in %), 2023 & 2033
Figure 64: Saudi Arabia Dementia Drugs Market (in US$ Million), 2019-2033
Figure 65: Turkey Dementia Drugs Market (in US$ Million), 2019-2033
Figure 66: Iran Dementia Drugs Market (in US$ Million), 2019-2033
Figure 67: UAE Dementia Drugs Market (in US$ Million), 2019-2033
Figure 68: Market Value Chain


List of Tables

Table 1: Global Dementia Drugs Market Portraiture
Table 2: Global Dementia Drugs Market by Drug Class (in US$ Million), 2023 & 2033
Table 3: Global Dementia Drugs Market by Indication (in US$ Million), 2023 & 2033
Table 4: Global Dementia Drugs Market by Distribution Channel (in US$ Million), 2023 & 2033
Table 5: Global Dementia Drugs Market by Region (in US$ Million), 2023 & 2033
Table 6: Europe Dementia Drugs Market by Country (in US$ Million), 2023 & 2033
Table 7: North America Dementia Drugs Market by Country (in US$ Million), 2023 & 2033
Table 8: Asia Pacific Dementia Drugs Market by Country (in US$ Million), 2023 & 2033
Table 9: Latin America Dementia Drugs Market by Country (in US$ Million), 2023 & 2033
Table 10: Middle East & Africa Dementia Drugs Market by Country (in US$ Million),
2023 & 2033
Table 11: List of Key Players